Funding for this research was provided by:
Multiple Sclerosis Society (959/11)
Text and Data Mining valid from 2018-08-06
Received: 10 August 2017
Accepted: 1 August 2018
First Online: 6 August 2018
Ethics approval and consent to participate
: The U.K. National Research Ethics Service Committee South West – Exeter approved the study protocol (REC reference number: 12/SW/0322).
: Not applicable.
: MJD; Research grants, Speaker bureau, advisory boards for Allergan, Astellas, Ferring. Speaker bureau for Hikma and Pfizer. Other authors; not applicable.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.